321 related articles for article (PubMed ID: 12972482)
21. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
[TBL] [Abstract][Full Text] [Related]
22. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to hn-RNP protein A1 in systemic lupus erythematosus: clinical association with Raynaud's phenomenon and esophageal dysmotility.
Montecucco C; Caporali R; Cobianchi F; Negri C; Astaldi-Ricotti GC
Clin Exp Rheumatol; 1992; 10(3):223-7. PubMed ID: 1582066
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
26. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
27. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis.
Stratta P; Canavese C; Ciccone G; Santi S; Quaglia M; Ghisetti V; Marchiaro G; Barbui A; Fop F; Cavallo R; Piccoli G
Nephron; 1999 Jun; 82(2):145-54. PubMed ID: 10364707
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
29. Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohort of SLE patients. European Concerted Action on the Immunogenetics of SLE.
Galeazzi M; Bellisai F; Sebastiani GD; Morozzi G; Marcolongo R; Houssiau F; Cervera R; Levy Y; George J; Sherer Y; Shoenfeld Y
Clin Exp Rheumatol; 1998; 16(6):717-20. PubMed ID: 9844765
[TBL] [Abstract][Full Text] [Related]
30. BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus.
Picceli VF; Skare TL; Nisihara RM; Nass FR; Messias-Reason IT; Utiyama SR
Lupus; 2016 Apr; 25(4):412-7. PubMed ID: 26537423
[TBL] [Abstract][Full Text] [Related]
31. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
[TBL] [Abstract][Full Text] [Related]
32. Critical peripheral ischemia precipitated by severe episode of Raynaud's phenomenon in a patient with aPL-positive systemic lupus erythematosus, upon high titer anti-RNP seroconversion.
Levy O; Maslakov I; Vosco S; Markov A; Amit-Vazina M; Tishler M
Lupus; 2015 Mar; 24(3):327-30. PubMed ID: 25467391
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus.
Dimant J; Ginzler E; Schlesinger M; Sterba G; Diamond H; Kaplan D; Weiner M
Arthritis Rheum; 1979 Aug; 22(8):815-9. PubMed ID: 465096
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies.
Matsuda J; Saitoh N; Gotoh M; Gohchi K; Tsukamoto M
Ann Rheum Dis; 1995 Jan; 54(1):73-5. PubMed ID: 7880127
[TBL] [Abstract][Full Text] [Related]
35. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
Annese V; Tomietto P; Venturini P; D'Agostini S; Ferraccioli G
Reumatismo; 2006; 58(1):50-8. PubMed ID: 16639488
[TBL] [Abstract][Full Text] [Related]
36. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.
Carmo-Pereira S; Bertolaccini ML; Escudero-Contreras A; Khamashta MA; Hughes GR
Ann Rheum Dis; 2003 Jun; 62(6):540-3. PubMed ID: 12759291
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
[TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
39. Immunologic abnormalities in idiopathic Raynaud's phenomenon.
Moutsopoulos HM; Constantopoulos S; Gerber LH; Lawley TJ
Clin Exp Rheumatol; 1983; 1(1):45-8. PubMed ID: 6681124
[TBL] [Abstract][Full Text] [Related]
40. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
